Features Merck-Pandion acquisition: re-balancing immune response to treat autoimmune disease Allie Nawrat
Features Veteran investor Dr Robert Glassman talks life sciences, immunotherapy and Umoja Allie Nawrat
Features Q&A with SVB’s Nooman Haque: what does 2021 have in store for healthcare investment? Allie Nawrat
Features Bispecific antibodies and cancer: Lilly and Merus team up on T cell engager therapies Allie Nawrat
Features Exploring dark antigens: Enara and Boehringer Ingelheim sign oncology partnership Allie Nawrat
Features Inhibiting DDR pathways: Artios and the Merck Group team up on oncology drug discovery Allie Nawrat
Features Applying AI to global health challenges: Gates Foundation awards $4.2m to Exscientia Allie Nawrat